Skip to main content
. 2020 Aug 1;46(6):423–426. doi: 10.1016/j.diabet.2020.07.006

Table 1.

Suggested mechanisms to explain the possible positive effects of metformin on COVID-19 outcomes.

Mechanisms References
Improved glucose control Ceriello et al. [5], [6]
Reduction in body weight El-Arabey and Abdalla [20]
Reduction in insulin resistance Penlioglou et al. [16]
Sharma et al. [17]
AMPK activation leads to phosphorylation of ACE2, thereby inhibition of virus penetration Sharma et al. [17]
Inhibition of mTOR pathway and prevention of immune hyperactivation Sharma et al. [17]
Bolourian and Mojtahedi [21]
Lehrer [22]
Action on endosomal Na+/H+ exchanger, thereby increasing cellular pH and interference with viral endocytic cycle Esam [23]
Anti-inflammatory properties Kumar Singh and Singh [18]
Reduction in neutrophils Dalan [24]
Inhibition of mitochondrial complex 1, suppression of mitochondrial reactive oxygen species (ROS) signalling, ROS prevention: CRAC-mediated interleukin-6 release Menendez [25]

AMPK: AMP-activated protein kinase; ACE2: angiotensin-converting enzyme 2; mTOR: mammalian target of rapamycin; CRAC: Ca2+ release-activated Ca2+ channels.